BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 23577575)

  • 1. Correlation between expression of extracellular matrix metalloproteinase inducer and matrix metalloproteinase-2 and cervical lymph node metastasis of nasopharyngeal carcinoma.
    Huang T; Chen MH; Wu MY; Wu XY
    Ann Otol Rhinol Laryngol; 2013 Mar; 122(3):210-5. PubMed ID: 23577575
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Expressions of COX-2 and MMP-2 in nasopharyngeal carcinoma and the their relationship with lymph node metastasis].
    Cui D; Zhang X; Fu Y
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2008 Aug; 22(15):692-4. PubMed ID: 18950008
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor progression driven by pathways activating matrix metalloproteinases and their inhibitors.
    Bodnar M; Szylberg Ł; Kazmierczak W; Marszalek A
    J Oral Pathol Med; 2015 Jul; 44(6):437-43. PubMed ID: 25244188
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Matrix metalloproteinase 2 and 9 as the factor of head and neck tumor metastasis].
    Kondakova IV; Klisho EV; savenkova OV; Kakurina GV; Choĭnzonov EL; Shishkin DA; Mukhamedov MP
    Biomed Khim; 2008; 54(5):555-60. PubMed ID: 19105397
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Expression of RECK, RAGE and MMP-9 in nasopharyngeal carcinoma and its significance].
    Li R; Deng Y
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2010 Sep; 24(18):823-7. PubMed ID: 21254649
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gelatinase A, membrane type 1 matrix metalloproteinase, and extracellular matrix metalloproteinase inducer mRNA expression: correlation with invasive growth of breast cancer.
    Dalberg K; Eriksson E; Enberg U; Kjellman M; Bäckdahl M
    World J Surg; 2000 Mar; 24(3):334-40. PubMed ID: 10658069
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Upregulated EMMPRIN/CD147 might contribute to growth and angiogenesis of gastric carcinoma: a good marker for local invasion and prognosis.
    Zheng HC; Takahashi H; Murai Y; Cui ZG; Nomoto K; Miwa S; Tsuneyama K; Takano Y
    Br J Cancer; 2006 Nov; 95(10):1371-8. PubMed ID: 17088917
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunohistochemical levels of matrix metalloproteinase-2 and CD44 variant 6 protein in the diagnosis and lateral cervical lymph node metastasis of papillary thyroid carcinoma.
    Wu G; Zhou Y; Li T; Guo J; Zhou Z
    J Int Med Res; 2013 Jun; 41(3):816-24. PubMed ID: 23685894
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Study of the relation between MMP2, MMP9 and nasopharyngeal carcinoma].
    Zhang X; Guo Y; Ye Q; Yang Z; Dong Z
    Lin Chuang Er Bi Yan Hou Ke Za Zhi; 1999 Aug; 13(8):356-8. PubMed ID: 12541362
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ADAM17 is associated with EMMPRIN and predicts poor prognosis in patients with uterine cervical carcinoma.
    Xu Q; Ying M; Chen G; Lin A; Xie Y; Ohara N; Zhou D
    Tumour Biol; 2014 Aug; 35(8):7575-86. PubMed ID: 24793016
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhanced control by radiotherapy of cervical lymph node metastases arising from nasopharyngeal carcinoma compared with nodal metastases from other head and neck squamous cell carcinomas.
    Chow E; Payne D; Keane T; Panzarella T; Izard MA
    Int J Radiat Oncol Biol Phys; 1997 Aug; 39(1):149-54. PubMed ID: 9300749
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overexpression of FOXM1 is associated with metastases of nasopharyngeal carcinoma.
    Jiang L; Wang P; Chen H
    Ups J Med Sci; 2014 Nov; 119(4):324-32. PubMed ID: 25231007
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overexpression of EMMPRIN isoform 2 is associated with head and neck cancer metastasis.
    Huang Z; Tan N; Guo W; Wang L; Li H; Zhang T; Liu X; Xu Q; Li J; Guo Z
    PLoS One; 2014; 9(4):e91596. PubMed ID: 24705283
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Expression and correlation with metastasis of E-cadherin, CD44H, matrix metalloproteinase-3, nm23H1 and VEGF in nasopharyngeal carcinoma].
    Wang S; Jiang Y; Huang H; Yang Q
    Lin Chuang Er Bi Yan Hou Ke Za Zhi; 2004 Aug; 18(8):470-2. PubMed ID: 15571312
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combined inhibition of EMMPRIN and epidermal growth factor receptor prevents the growth and migration of head and neck squamous cell carcinoma cells.
    Suzuki S; Ishikawa K
    Int J Oncol; 2014 Mar; 44(3):912-7. PubMed ID: 24379084
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlation between IL-17A expression in nasopharyngeal carcinoma tissues and cells and pathogenesis of NPC in endemic areas.
    Wang LX; Ma RX; Di LL; Peng XB; Kang ZP; Zhong S
    Eur Arch Otorhinolaryngol; 2019 Nov; 276(11):3131-3138. PubMed ID: 31456038
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aberrant expression levels of MTA1 and RECK in nasopharyngeal carcinoma: association with metastasis, recurrence, and prognosis.
    Deng YF; Zhou DN; Ye CS; Zeng L; Yin P
    Ann Otol Rhinol Laryngol; 2012 Jul; 121(7):457-65. PubMed ID: 22844865
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlation of the expressions of IGF1R-RACK1-STAT3 and Bcl-xl in nasopharyngeal carcinoma with the clinicopathological features and prognosis of nasopharyngeal carcinoma.
    Wang S; Shen M; Wen X; Han XR; Wang YJ; Fan SH; Zhuang J; Zhang ZF; Shan Q; Li MQ; Hu B; Sun CH; Ge X; Lei QM; Wu DM; Lu J; Zheng YL
    J Cell Biochem; 2018 Feb; 119(2):1931-1941. PubMed ID: 28816378
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Upregulation of caveolin-1 and CD147 expression in nasopharyngeal carcinoma enhanced tumor cell migration and correlated with poor prognosis of the patients.
    Du ZM; Hu CF; Shao Q; Huang MY; Kou CW; Zhu XF; Zeng YX; Shao JY
    Int J Cancer; 2009 Oct; 125(8):1832-41. PubMed ID: 19582878
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CCL2-CCR2 axis promotes metastasis of nasopharyngeal carcinoma by activating ERK1/2-MMP2/9 pathway.
    Yang J; Lv X; Chen J; Xie C; Xia W; Jiang C; Zeng T; Ye Y; Ke L; Yu Y; Liang H; Guan XY; Guo X; Xiang Y
    Oncotarget; 2016 Mar; 7(13):15632-47. PubMed ID: 26701209
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.